in a raging pandemic, even those results, given t

Quote:

---

in a raging pandemic, even those results, given the safety profile, should have resulted in EUAEmergency Use Authorization , at minimum.

---

100% agree. In normal times, a drug that fails primary endpoint you demand more trials. In a deadly pandemic, you look beyond the PE because our collective data AT MINIMUM strongly suggests it works AND it’s completely safe… so start jabbing patients and see what happens.

Because this isn’t normal times.